Orthofix International | OFIX - Operating Profit


Orthofix International reported $6.12M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 9.66M 9.14M Jun/2026
Dexcom USD 255.3M 67.7M Mar/2026
EDAP TMS EUR -4.92M 843K Sep/2025
Globus Medical USD 164M 17.31M Mar/2026
Inogen USD -7.79M 728K Sep/2024
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
J&J USD 7.48B 860M Jun/2026
Medtronic USD 2.09B 354M Mar/2026
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD 6.12M 1.91M Dec/2025
Plus Therapeutics USD -5.74M 1.26M Dec/2025
Smith & Nephew USD 440M 50M Dec/2025
STAAR Surgical USD 17.4M 28.34M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 37.03M 686K Mar/2026
Veracyte USD 19.08M 5.55M Mar/2026
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026